These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 830417)

  • 21. Expression of differentiation-specific proteins in preneoplastic mammary tissues in BALB/c mice.
    Medina D; Schwartz M; Taha M; Oborn CJ; Smith GH
    Cancer Res; 1987 Sep; 47(17):4686-93. PubMed ID: 3621162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and characterization of the BALB/cNIV mouse strain.
    Young LJ; DeOme KB; Blair PB; Pitelka DR; Cardiff RD
    Cancer Res; 1984 Oct; 44(10):4333-6. PubMed ID: 6088036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiogenic capacity of preneoplastic lesions of the murine mammary gland as a marker of neoplastic transformation.
    Gimbrone MA; Gullino PM
    Cancer Res; 1976 Jul; 36(7 PT 2):2611-20. PubMed ID: 1277168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associated effects of bromocriptine on neoplastic progression of mouse mammary preneoplastic hyperplastic alveolar nodule line C4 and on hyperplastic alveolar nodule-infiltrating and splenic lymphocyte function.
    Tsai SJ; Loeffler DA; Heppner GH
    Cancer Res; 1992 Apr; 52(8):2209-15. PubMed ID: 1559224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of hyperplastic alveolar nodule outgrowth-line D1 to mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation acting singly and in combination.
    Medina D; DeOme KB
    J Natl Cancer Inst; 1969 Feb; 42(2):303-10. PubMed ID: 4303882
    [No Abstract]   [Full Text] [Related]  

  • 26. Recovery of transformed nodule and ductal mammary cells from carcinogen-treated C57BL mice.
    Guzman RC; Osborn RC; DeOme KB
    Cancer Res; 1981 May; 41(5):1808-11. PubMed ID: 6783300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preferential growth of mammary tumors in intact mammary fatpads.
    Miller FR; Medina D; Heppner GH
    Cancer Res; 1981 Oct; 41(10):3863-7. PubMed ID: 7284994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinogen-induced mammary tumors from preneoplastic nodule outgrowths in BALB-c mice.
    Medina D; DeOme KB
    Cancer Res; 1970 Apr; 30(4):1055-9. PubMed ID: 5504348
    [No Abstract]   [Full Text] [Related]  

  • 30. Growth factor dependency and gene expression in preneoplastic mouse mammary epithelial cells.
    Medina D; Kittrell FS; Oborn CJ; Schwartz M
    Cancer Res; 1993 Feb; 53(3):668-74. PubMed ID: 8425201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinction between preneopastic and neoplastic mammary cell populations in vitro by cytochalasin B-induced multinucleation.
    Medina D; Oborn CJ; Asch BB
    Cancer Res; 1980 Feb; 40(2):329-33. PubMed ID: 7356516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reevaluation of the effect of mouse mammary tumor virus infection on the BALB/c mouse hyperplastic outgrowth.
    Ashley RL; Cardiff RD; Fanning TG
    J Natl Cancer Inst; 1980 Nov; 65(5):977-86. PubMed ID: 6253710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of antigenicity of mammary tumors induced by carcinogens in a nonantigenic preneoplastic lesion.
    Halpin ZT; Vaage J; Blair PB
    Cancer Res; 1972 Oct; 32(10):2197-200. PubMed ID: 5080764
    [No Abstract]   [Full Text] [Related]  

  • 34. Combined effects of 3-methylcholanthrene, mammary tumor virus, nodule-inducing virus, and prolonged hormonal stimulation on the tumor-producing capabilities of the nodule outgrowth line D1.
    Medina D; Faulkin LJ; DeOme KB
    J Natl Cancer Inst; 1970 Jan; 44(1):159-65. PubMed ID: 11515027
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of selenium on mouse mammary tumorigenesis and glutathione peroxidase activity.
    Medina D; Lane H; Shepherd F
    Anticancer Res; 1981; 1(6):377-82. PubMed ID: 6807190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor subpopulation interactions affecting melphalan sensitivity in palpable mouse mammary tumors.
    Miller BE; Machemer T; Lehotan M; Heppner GH
    Cancer Res; 1991 Aug; 51(16):4378-87. PubMed ID: 1868461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced cytostatic effectiveness of aniline mustard against 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors during regression in response to ovariectomy.
    Benckhuysen C; Ter Hart HG; Van Dijk PJ
    Cancer Treat Rep; 1981; 65(7-8):567-74. PubMed ID: 6788369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stroma is not a major target in DMBA-mediated tumorigenesis of mouse mammary preneoplasia.
    Medina D; Kittrell F
    J Cell Sci; 2005 Jan; 118(Pt 1):123-7. PubMed ID: 15585572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammary gland as a morphological end point in carcinogenesis studies.
    Medina D
    J Toxicol Environ Health; 1976 Mar; 1(4):551-60. PubMed ID: 177787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of ductal dysplasia in mammary outgrowths derived from carcinogen-treated virgin female BALB/c mice.
    Ethier SP; Ullrich RL
    Cancer Res; 1982 May; 42(5):1753-60. PubMed ID: 6802483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.